Search results
Vertex Pharmaceuticals executive sells shares worth over $13k By Investing.com
Investing.com· 6 days agoIn a recent transaction, Amit Sachdev, the Executive Vice President and Chief Patient & External...
Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending Stock
Zacks via Yahoo Finance· 19 hours agoRecursion Pharmaceuticals (RXRX) has been one of the stocks most watched by Zacks.com users lately....
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 days agos why Novavax is a better bet among these two companies, even though its market capitalization is much higher at $1.87 billion. With that said, Novavax...
Delivra Health Brands Inc.'s (CVE:DHB) Profit Outlook
Simply Wall St. via Yahoo Finance· 18 hours agoBelow we will provide a high-level summary of the industry analysts’ expectations for the company....
3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years
Motley Fool via Yahoo Finance· 21 hours agoIt is still a leader in the streaming industry with just under 270 million paid subscribers....
‘It made my penis change shape’: Inside the hair loss drug controversy
The Telegraph via Yahoo News· 2 days agoA few years ago, James* was at the pub with colleagues when a female co-worker walked behind him to...
Is It Too Late to Buy Viking Therapeutics Stock? | The Motley Fool
The Motley Fool· 2 days agoUp 260% so far this year, shares of Viking Therapeutics (VKTX -1.90%) are a hot commodity thanks to...
Joe Biden’s Most Potent Message Isn’t Reaching The Voters He’s Aiming For
HuffPost via Yahoo News· 4 days agoJohn Sarbanes (D-Md.), retiring from Congress this year after leading the House’s efforts on the...
3 Biotech Stocks to Buy on the Dip: May 2024
InvestorPlace· 14 hours agoDespite their exciting growth potential and undeniable rewards, investors have been selling these stocks, causing a slight dip in price. Pfizer (NYSE:PFE) is a giant in biopharma, offering unique ...
Rescheduling Marijuana FAQs: How Do I Submit Comments on DEA’s Proposed Rules? | JD Supra
JD Supra· 4 days agoOn May 16, 2024, the U.S. Drug Enforcement Administration (DEA) released the proposed rule (Proposed Rule) to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances ...
